[New therapeutic trends in vulvovaginitis caused by mixed bacterial flora. Controlled clinical study of a new preparation with trichomonocidal and antimycotic activity].
D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008875:Middle Aged; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D014627:Vaginitis / Q000188:drug therapy*; D014848:Vulvovaginitis / Q000188:drug therapy*
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D004338:Drug Combinations
Nuovi indirizzi terapeutici delle vulvo-vaginiti a flora batterica mista. Ricerca clinica controllata su un nuovo preparato ad attività trichomonicida ed antimicotica.